Tolerance and Activity Assessment of High Doses of Favipiravir in Male Survivors With Ebola Virus in the Semen
Phase of Trial: Phase II
Latest Information Update: 06 May 2016
At a glance
- Drugs Favipiravir (Primary)
- Indications Ebola virus infections
- Focus Adverse reactions
- Acronyms FORCE
- 03 May 2016 Status changed from not yet recruiting to recruiting.
- 18 Apr 2016 New trial record
- 15 Apr 2016 Time frame of primary end point is been changed from 21 days to 14 days.